Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...
Novartis is buying Myricx to internalize an NMTi-based ADC payload platform intended to expand ADC applicability and ...
It is also why I have spent over fifteen years building around a conviction the healthcare industry still resists: when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results